drugset / Trial / NCT00244192

Effects of Infliximab (Remicade) on Fat Free Mass in Patients With Moderate to Severe COPD Suffering From Cachexia

NCT00244192

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine whether infliximab is effective on fat-free mass in the treatment of patients with moderate to severe COPD suffering from cachexia.

Timeline

Start
2003-10
Primary completion
Completion
2005-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Infliximab Monoclonal antibody 5 mg/kg